Journal of Molecular Structure, Volume 1357 , 15/04/2026
Design, Synthesis and Computational Insights of 7-Hydroxystilbene-Coumarin Hybrid Scaffolds as SARS-CoV-2 3CLpro Inhibitors
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused of COVID-19 has posed a major global health crisis in 2019. Herein, six stilbene-coumarin derivatives were synthesized from the natural chalcone dimethylcardamonin (DMC, 5) isolated from Syzygium nervosum. Their antiviral potential against COVID-19 was evaluated by measuring the inhibition of the SARS-CoV-2 main protease (3CL<sup>pro</sup>), a biological macromolecule, using FRET-based enzymatic assay. The results demonstrated that this scaffold effectively suppressed the proteolytic activity of 3CL<sup>pro</sup>. Structure-activity relationship analysis indicated that an optimal alkyl substitution length at C-3 position of the coumarin ring comprises six carbon atoms. Among the synthesized derivatives, compound 7c exhibited the strongest inhibitory activity, with an IC<inf>50</inf> value of 20.73 µM, approximately four times more potent than the reference flavonoid baicalein. Furthermore, molecular dynamics simulation provided atomistic insights into the interactions between the stilbene-coumarin derivatives and 3CL<sup>pro</sup>, revealing plausible binding orientations within the active site. Complementary, Molecular Mechanics Generalized Born Surface Area (MM-GBSA) and fragment molecular orbital (FMO) calculations highlighted key residues that play critical roles in stabilizing the binding of these compounds.
Document Type
Article
Source Type
Journal
Keywords
CoumarinSARS-CoV-2Stilbene
ASJC Subject Area
Chemistry : Analytical ChemistryChemistry : SpectroscopyChemistry : Organic ChemistryChemistry : Inorganic Chemistry
Funding Agency
Walailak University
Khamto, N., Pruksaphon, K., Akkravijitkul, N., Choommongkol, V., Patnin, S., & Meepowpan, P. (2026). Design, Synthesis and Computational Insights of 7-Hydroxystilbene-Coumarin Hybrid Scaffolds as SARS-CoV-2 3CLpro Inhibitors. Journal of Molecular Structure, 1357doi:10.1016/j.molstruc.2026.145240